| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |